Bringing you the latest Business News updates from the science industry Microscopy
Daren Sheward, Operations Manager, leads a tour of EVO scanning electron microscope production line
The UK manufacturing and sales divisions of Carl Zeiss have cemented their roots in Cambridge with an expansion of their existing production site and the construction of new application laboratories, sales and service offices and customer facilities.
Coldhams Lane in Cambridge has been home to Carl Zeiss Microscopy Ltd for some years. Due to the sustained growth in
Asylum Research Adds Application Scientist to Team
py News by Heather Hobbs Zeiss Invests in UK Operations
international orders, the business had acquired neighbouring premises in order to increase production of their scanning electron microscopes, including EVO, ∑IGMA and process specific tools.
This provided opportune timing for the UK Sales and Service business, Carl Zeiss Ltd, to relocate from Welwyn Garden City to Cambridge where one larger campus could be formed. The new building has taken on Head Office status for both Carl Zeiss Microscopy Ltd and Carl Zeiss Ltd. The new facilities officially opened in February include 5 application laboratories for electron and light and microscopes as well as demonstration and training facilities for surgical microscopes, medical diagnostic equipment, camera lenses, binoculars and scopes.
The first recorded sale in the UK for the German-owned company stems back to 1851. Furthermore, as Cambridge Scientific Instruments, the company designed and developed the world’s first commercial scanning electron microscope in 1965. It is clear from today’s modern business that its long history has paved the way for its success as an international leader in the field of optics and opto-electronics
Paul Adderley, Managing Director for Carl Zeiss Ltd, commented “Customers from several of the Carl Zeiss business groups, including Microscopy, Medical Technology, Camera Lenses and Sports Optics, will be able to visit us in Cambridge, the hub for innovative technology,
Customer experiments with the brand new Trenion 3D HD system from the Meditec division of Carl Zeiss
for product demonstrations and expert applications support in our new facilities.”
The Cambridge site is one of a number of construction projects currently underway around the world. The end goal is to achieve a modern working environment for all employees with a consistent corporate design and welcoming environment for customers.
MORE INFO. 173
Euro-BioImaging Project: 1st Open Call for Nodes
Euro-BioImaging, the pan-European open access research infrastructure for biological and medical imaging technologies, invites leading European imaging facilities to submit proposals to participate. Applications to become a Euro-BioImaging node, which will accepted up to 30th April 2013, will be reviewed by a board of independent international experts.
Successful facilities will be able to upgrade their capacity in order to attract and serve transnational users, with funding secured from agencies in the node’s host country, together with the facility itself and Euro-BioImaging.
Cutting-edge and innovative imaging technologies are revolutionising the life sciences. Recent developments enable scientists to visualise and thereby better understand the processes that govern life and disease in cells and organisms. However, European life scientists often lack access to innovative imaging technologies and this can slow down scientific discoveries.
Euro-BioImaging aims to fill this gap by creating a network of geographically distributed but strongly interlinked imaging facilities.
Asylum Research has appointed Florian Johann (pictured above) as its newest Applications Scientist. Johann will be based in the Mannheim, Germany office and will support customers throughout Germany and continental Europe.
“We are very excited about adding Florian Johann to the outstanding list of talented Applications Scientists at Asylum in general and specifically here at our office in Germany,” said Ludger Weisser, Director of European Sales for Asylum Research Germany. “His AFM background in materials science will complement the research that is being done on next-generation materials by leading labs throughout Germany and Europe. Florian will also enable us to expand the personalised applications support that we offer to all of our customers. Our goal is to expand our scientific staff in the region to provide the best, most comprehensive customer service, support and accessibility to our customers," commented Roger Proksch, President of Asylum Research. "Florian will enable us to continue to build our strong partnerships in the region, with great science being the ultimate result."
MORE INFO. 175
Euro-BioImaging Nodes will provide open access to advanced imaging technology for all European life scientists.
“Access to cutting-edge imaging technologies is a growing challenge for European scientists even though they are ready to travel long distances to carry out experiments with the best technology,” explains Jan Ellenberg, scientific coordinator of the project at EMBL. “Euro- BioImaging will provide access to the latest equipment, at a reasonable cost and distance. This will be a unique advantage for the European life science community – it will foster many new discoveries in biology and medicine, and drive innovation of imaging technology.”
Euro-BioImaging’s preparatory phase has been funded by the EU and coordinated by EMBL in Heidelberg. Since 2010, the 39 Euro- BioImaging partners from 15 different European countries have prepared the technological, legal and governmental framework to construct this new European research infrastructure. The project is now in the last year of the planning phase: this 1st call for nodes is the basis to start construction.
MORE INFO. 174
Oxford Instruments Focuses on Fundamental and Applied Sciences with Strengthened Team
Oxford Instruments has announced a sharpened focus on fundamental and applied sciences by merging its Omicron NanoTechnology and nanoscience businesses to form Oxford Instruments Omicron NanoScience.
The acquisition of Omicron in 2011 brought Scanning Probe Microscopy, Electron Spectroscopy and Thin Film Deposition Techniques into Oxford Instruments NanoScience’s portfolio which already offered cryogenics and superconducting technology. The
newly named company now concentrates the strengths of these two established brands and experienced support teams into a single business unit.
Dr Ferdinand Bartels, Managing Director of Oxford Instruments Omicron NanoScience says “I am very proud to be leading such a talented and professional team. Our new business will be focused on delivering excellence, both in our technology and our service and I look forward to an exciting future."
MORE INFO. 176
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
